Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease

Vaccine

Volumn 29, Issue 46, 2011, Pages 8257-8266

  Li, Yongqing ^a,c   Reddy, Kolli ^a   Reid, Scott M ^b   Cox, William J ^b   Brown, Ian H ^b   Britton, Paul ^a   Nair, Venugopal ^a   Iqbal, Munir ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

^c INSTITUTE OF PLANT AND ENVIRONMENT PROTECTION   (China)

Author keywords

Highly pathogenic H7N1 avian influenza virus; Marek's disease; Multivalent vaccine; Poultry; Recombinant herpesvirus of turkeys; Vector based vaccine

Indexed keywords

HERPESVIRUS VECTOR; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AVIAN INFLUENZA; BACTERIAL ARTIFICIAL CHROMOSOME; CELL CULTURE; CHICK; CHICKEN; CONTROLLED STUDY; DNA MODIFICATION; EMBRYO; FIBROBLAST; GENE CONSTRUCT; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; HERPES VIRUS; IN VITRO STUDY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H7N1; MARDIVIRUS; MAREK DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TURKEY (BIRD); VIROGENESIS; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS SHEDDING; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DRUG CARRIERS; GENETIC VECTORS; HERPESVIRIDAE; INFLUENZA A VIRUS, H7N1 SUBTYPE; INFLUENZA IN BIRDS; MARDIVIRUS; MAREK DISEASE; POULTRY DISEASES; SURVIVAL ANALYSIS; TURKEYS; VIRAL VACCINES;

EID: 80053976193     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.115     Document Type: Article

References (36)

1. Alexander D.J., Brown I.H. History of highly pathogenic avian influenza. Rev Sci Tech 2009, 28(April (1)):19-38.
2. Alexander D.J. An overview of the epidemiology of avian influenza. Vaccine 2007, 25(July (30)):5637-5644.
3. Belser J.A., Bridges C.B., Katz J.M., Tumpey T.M. Past, present, and possible future human infection with influenza virus A subtype H7. Emerg Infect Dis 2009, 15(June (6)):859-865.
4. Capua I., Schmitz A., Jestin V., Koch G., Marangon S. Vaccination as a tool to combat introductions of notifiable avian influenza viruses in Europe, 2000 to 2006. Rev Sci Tech 2009, 28(April (1)):245-259.
5. Capua I., Alexander D.J. Avian influenza vaccines and vaccination in birds. Vaccine 2008, 26(September (Suppl. 4)):D70-D73.
6. Kapczynski D.R., Swayne D.E. Influenza vaccines for avian species. Curr Top Microbiol Immunol 2009, 333:133-152.
7. Swayne D.E. Avian influenza vaccines and therapies for poultry. Comp Immunol Microbiol Infect Dis 2009, 32(July (4)):351-363.
8. Hilleman M.R. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 2002, 20(August (25-26)):3068-3087.
9. Fuchs W., Romer-Oberdorfer A., Veits J., Mettenleiter T.C. Novel avian influenza virus vaccines. Rev Sci Tech 2009, 28(April (1)):319-332.
10. Ge J., Deng G., Wen Z., Tian G., Wang Y., Shi J., et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 2007, 81(January (1)):150-158.
11. Pavlova S.P., Veits J., Mettenleiter T.C., Fuchs W. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype. Vaccine 2009, 27(August (37)):5085-5090.
12. Sonoda K., Sakaguchi M., Okamura H., Yokogawa K., Tokunaga E., Tokiyoshi S., et al. Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies. J Virol 2000, 74(April (7)):3217-3226.
13. Chen H. H5N1 avian influenza in China. Sci China C Life Sci 2009, 52(May (5)):419-427.
14. Heckert R.A., Riva J., Cook S., McMillen J., Schwartz R.D. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens. Avian Dis 1996, 40(October-December (4)):770-777.
15. Reddy S.K., Sharma J.M., Ahmad J., Reddy D.N., McMillen J.K., Cook S.M., et al. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens. Vaccine 1996, 14(April (6)):469-477.
16. Cronenberg A.M., van Geffen C.E., Dorrestein J., Vermeulen A.N., Sondermeijer P.J. Vaccination of broilers with HVT expressing an Eimeria acervulina antigen improves performance after challenge with Eimeria. Acta Virol 1999, 43(April-June (2-3)):192-197.
17. Tsukamoto K., Saito S., Saeki S., Sato T., Tanimura N., Isobe T., et al. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens. J Virol 2002, 76(June (11)):5637-5645.
18. Baigent S.J., Petherbridge L.J., Smith L.P., Zhao Y., Chesters P.M., Nair V.K. Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease. J Gen Virol 2006, 87(April (Pt. 4)):769-776.
19. Cui H.Y., Wang Y.F., Shi X.M., An T.Q., Tong G.Z., Lan D.S., et al. Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens. J Virol Methods 2009, 156(March (1-2)):66-72.
20. Petherbridge L., Howes K., Baigent S.J., Sacco M.A., Evans S., Osterrieder N., et al. Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines. J Virol 2003, 77(August (16)):8712-8718.
21. Petherbridge L., Brown A.C., Baigent S.J., Howes K., Sacco M.A., Osterrieder N., et al. Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J Virol 2004, 78(December (23)):13376-13380.
22. Petherbridge L., Xu H., Zhao Y., Smith L.P., Simpson J., Baigent S., et al. Cloning of Gallid herpesvirus 3 (Marek's disease virus serotype-2) genome as infectious bacterial artificial chromosomes for analysis of viral gene functions. J Virol Methods 2009, 158(June (1-2)):11-17.
23. European Union Diagnostic manual for avian influenza. ; 2006 [accessed 18.08.11]. http://eur-lex.europa.eu/LexUriServ/site/en/oj/2006/l_237/l_23720060831en00010027.pdf.
24. Warming S., Costantino N., Court D.L., Jenkins N.A., Copeland N.G. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 2005, 33(4):e36.
25. Biggs P.M., Milne B.S. Biological properties of a number of Marek's disease virus isolates. Oncogenesis and Herpesviruses 1972, 88-94. IARC, Lyon, France. P.M. Biggs, G. de The, L.N. Payne (Eds.).
26. Cottey R, Rowe CA, Bender BS. Influenza virus. Curr Protoc Immunol 2001;(May (Chapter 19)):Unit 19 1.
27. WHO. WHO Manual on Animal Influenza Diagnosis and Surveillance. ; 2002 [accessed 18.08.11]. http://www.who.int/vaccine_research/diseases/influenza/WHO_manual_on_animal-diagnosis_and_surveillance_2002_5.pdf.
28. Londt B.Z., Nunez A., Banks J., Nili H., Johnson L.K., Alexander D.J. Pathogenesis of highly pathogenic avian influenza A/turkey/Turkey/1/2005 H5N1 in Pekin ducks (Anas platyrhynchos) infected experimentally. Avian Pathol 2008, 37(December (6)):619-627.
29. Sarma G., Greer W., Gildersleeve R.P., Murray D.L., Miles A.M. Field safety and efficacy of in ovo administration of HVT+SB-1 bivalent Marek's disease vaccine in commercial broilers. Avian Dis 1995, 39(April-June (2)):211-217.
30. Chambers T.M., Kawaoka Y., Webster R.G. Protection of chickens from lethal influenza infection by vaccinia-expressed hemagglutinin. Virology 1988, 167(December (2)):414-421.
31. Swayne D.E., Beck J.R., Kinney N. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Dis 2000, 44(January-March (10):132-137.
32. Nili H., Essen S., Nunez A., Banks J., Brown I.H. Pathological lesions observed in chickens pre-infected with LP H7N1 A/CK/Italy/1279/99 avian influenza and challenged with homologous H7N1 a/ostrich/Italy/984/00. Iran J Vet Res 2008, 9(3):233-239.
33. Veits J., Luschow D., Kindermann K., Werner O., Teifke J.P., Mettenleiter T.C., et al. Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. J Gen Virol 2003, 84(December (Pt. 12)):3343-3352.
34. Rauw F., Palya V., Van Borm S., Welby S., Tatar-Kis T., Gardin Y., et al. Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains. Vaccine 2011, 29(March (14)):2590-2600.
35. Wang S., Taaffe J., Parker C., Solorzano A., Cao H., Garcia-Sastre A., et al. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines. J Virol 2006, 80(December (23)):11628-11637.
36. Veits J., Romer-Oberdorfer A., Helferich D., Durban M., Suezer Y., Sutter G., et al. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. Vaccine 2008, 26(March (13)):1688-1696.